Willmann Raffaella, Possekel Stefanie, Dubach-Powell Judith, Meier Thomas, Ruegg Markus A
Biozentrum, University of Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland.
Neuromuscul Disord. 2009 Apr;19(4):241-9. doi: 10.1016/j.nmd.2008.11.015. Epub 2009 Feb 12.
Duchenne muscular dystrophy (DMD) is a fatal neuromuscular disease that affects boys and leads to early death. In the quest for new treatments that improve the quality of life and in the search for a possible definitive cure, the use of animal models plays undoubtedly an important role. Therefore, a number of different mammalian models for DMD have been described. Much knowledge on the molecular mechanisms underlying the disease has arisen from studies in these animals. However, the use of different models does not often allow a direct comparison of results obtained in preclinical trials and therefore hinders a straightforward translational research. In the frame of "TREAT-NMD", a European Network of Excellence addressing the fragmentation in the assessment and treatment of neuromuscular diseases, we compare here the currently used mammalian animal models for DMD with the aim of selecting and recommending the most appropriate ones for preclinical efficacy testing of new therapeutic strategies.
杜氏肌营养不良症(DMD)是一种致命的神经肌肉疾病,影响男孩并导致过早死亡。在寻求改善生活质量的新疗法以及寻找可能的根治方法的过程中,动物模型的使用无疑起着重要作用。因此,已经描述了多种不同的DMD哺乳动物模型。对这些动物的研究产生了许多关于该疾病潜在分子机制的知识。然而,使用不同的模型往往无法直接比较在临床试验前获得的结果,因此阻碍了直接的转化研究。在“TREAT-NMD”框架内,这是一个致力于解决神经肌肉疾病评估和治疗碎片化问题的欧洲卓越网络,我们在此比较目前用于DMD的哺乳动物动物模型,目的是选择并推荐最适合新治疗策略临床前疗效测试的模型。